U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07703683) titled 'Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases' on May 15.
Brief Summary: Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population.
.
Study Start Date: Feb. 19
Study Type: OBSERVATIONAL
Condition:
Diabetes
Obesity & Overweight
Cushing Syndrome
Metabolic Diseases
Endocrine Diseases
Sarcopenia
Sarcopenic Obesity
Intervention:
DRUG: GLP-1 Receptor Agoni...